BeStock  

Fulgent Genetics FLGT

US equityMarket cap rank #3412Diagnostics & Research
$24.12 −$0.66 (-2.66%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $24.12 0.00%
Open$24.50
Prev close$24.78
Day range$23.88 – $24.79
Volume323.0K
Market cap$673.89M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$90.41M+7.5% YoY
Operating profit-$22.55M-46.9% YoY
Net profit-$13.34M-95.4% YoY
Diluted EPS-$0.48-128.6% YoY
Free cash flow$107.44M+2,024.7% YoY
Operating cash flow$109.23M

Revenue, last 8 quarters

$76.2MDec '24$73.5MMar '25$81.8MJun '25$84.1MSep '25$83.3MDec '25$71.1MMar '26$85.4MJun '26$90.4MSep '26

Net profit, last 8 quarters

$-6.2MDec '24$-11.9MMar '25$-19.3MJun '25$-6.8MSep '25$-23.7MDec '25$-25.3MMar '26$-29.7MJun '26$-13.3MSep '26

Diluted EPS by quarter

-0.19Dec '24-0.37Mar '25-0.62Jun '25-0.21Sep '25-0.76Dec '25-0.80Mar '26-1.05Jun '26-0.48Sep '26

Free cash flow by quarter

$21.2MDec '24$-9.1MMar '25$-37.0MJun '25$5.1MSep '25$-83.1MDec '25$1.9MMar '26$-27.6MJun '26$107.4MSep '26

Annual revenue

$421.7MFY20$992.6MFY21$619.0MFY22$289.2MFY23$283.5MFY24$322.7MFY25

Profitability & balance sheet

Gross margin33.8%
Operating margin-38.5%
Net margin-27.5%
Return on equity-8.6%
Return on assets-7.9%
Return on invested capital-11.2%
Current ratio5.34
Liabilities / assets8.7%
Cash & investments$292.74M
Total debt$8.17M
Net cash (debt)$284.57M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $90.41M $85.39M $71.14M $322.67M $83.34M
Total Operating Revenue $90.41M $85.39M $71.14M $322.67M $83.34M
Cost of Revenue $58.47M $59.71M $49.65M $191.80M $50.75M
Gross Profit $31.95M $25.68M $21.49M $130.88M $32.58M
Operating Expense $54.49M $59.58M $56.11M $221.97M $68.82M
Selling and Admin Expenses $38.37M $42.42M $39.91M $160.04M $52.62M
-Selling & Marketing Expense $15.61M $15.23M $12.22M $43.37M $10.98M
-General & Admin Expense $22.76M $27.20M $27.68M $116.66M $41.65M
Research & Development $13.64M $14.55M $14.18M $53.91M $14.17M
Depreciation & Amortization & Depletion $2.49M $2.60M $2.03M $8.03M $2.03M
-Depreciation & Amortization $2.49M $2.60M $2.03M $8.03M $2.03M
Operating Profit -$22.55M -$33.90M -$34.62M -$91.10M -$36.24M
Net Non-Operating Interest Income (Expense) $8.55M $6.35M $8.63M $30.84M $6.92M
Non-Operating Interest Income $8.55M $6.40M $8.65M $30.92M $6.94M
Non-Operating Interest Expense $7,000.00 $59,000.00 $17,000.00 $75,000.00 $16,000.00
Other Income (Expense) -$43,000.00 -$2.13M $10,000.00 -$9.77M $44,000.00
Special Income (Charges) $0.00 -$2.17M – -$9.93M $0.00
-Less:Impairment of Capital Assets $0.00 $2.17M – $0.00 $0.00
-Less:Write Off $0.00 $0.00 – $9.93M $0.00
Other Non-Operating Income (Expenses) -$43,000.00 $38,000.00 $10,000.00 $153,000.00 $44,000.00
Pretax Profit -$14.04M -$29.69M -$25.98M -$70.03M -$29.27M
Tax -$704,000.00 $29,000.00 -$704,000.00 -$8.39M -$5.62M
Net Profit -$13.34M -$29.72M -$25.27M -$61.63M -$23.65M
Profit from Continuing Operations -$13.34M -$29.72M -$25.27M -$61.63M -$23.65M
Minority Interests -$187,000.00 -$189,000.00 -$448,000.00 -$1.12M -$232,000.00
Net Income to Parent Company -$13.15M -$29.53M -$24.83M -$60.51M -$23.42M
Net Income to Common Stockholders -$13.15M -$29.53M -$24.83M -$60.51M -$23.42M
Basic EPS -$0.48 -$1.05 -$0.80 -$1.97 -$0.76
Diluted EPS -$0.48 -$1.05 -$0.80 -$1.97 -$0.76

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.08B $1.09B $1.16B $1.21B $1.21B
Total Current Assets $383.74M $454.77M $479.04M $550.49M $550.49M
Cash and Cash Equivalents & Short-Term Investments $292.74M $257.03M $276.30M $336.08M $336.08M
-Cash and Cash Equivalents $86.79M $26.31M $23.40M $50.19M $50.19M
-Short Term Investments $205.95M $230.73M $252.90M $285.88M $285.88M
Receivables $69.17M $70.53M $75.74M $91.61M $91.61M
-Accounts Receivable $62.49M $64.94M $69.28M $84.76M $84.76M
-Accrued Interest Receivable $5.37M $4.13M $5.38M $5.71M $5.71M
-Other Receivables $1.31M $1.46M $1.08M $1.13M $1.13M
Prepaid Assets $9.62M $115.55M $114.95M $112.20M $112.20M
Inventory $12.21M $11.67M $12.06M $10.60M $10.60M
Total Non-Current Assets $695.19M $634.45M $677.33M $663.04M $663.04M
Net PPE $110.74M $113.07M $116.34M $112.55M $112.55M
-Gross PPE $176.67M $177.36M $177.65M $170.49M $170.49M
-Accumulated Depreciation -$65.93M -$64.30M -$61.31M -$57.95M -$57.95M
Investments and Advances $359.55M $294.32M $328.29M $369.27M $369.27M
-Available for Sale Securities $359.55M $294.32M $328.29M $369.27M $369.27M
Goodwill and Other Intangible Assets $200.66M $203.12M $207.72M $158.36M $158.36M
-Goodwill $53.86M $53.86M $53.73M $25.08M $25.08M
-Other Intangible Assets $146.80M $149.26M $153.99M $133.28M $133.28M
Other Non-Current Assets $24.25M $23.95M $24.98M $22.86M $22.86M
Total Liabilities $94.22M $93.24M $112.22M $106.81M $106.81M
Total Current Liabilities $71.88M $71.76M $90.13M $84.97M $84.97M
Payables $16.97M $15.56M $21.13M $18.65M $18.65M
-Accounts Payable $16.97M $15.56M $21.13M $18.65M $18.65M
Current Accrued Expenses $9.97M $12.52M $24.39M $22.14M $22.14M
Short-Term Debt and Capital Lease Obligation $2.60M $2.34M $2.41M $1.94M $1.94M
-Current Debt $482,000.00 $482,000.00 $482,000.00 $476,000.00 $476,000.00
-Current Capital Lease Obligation $2.11M $1.86M $1.93M $1.46M $1.46M
Current Deferred Liabilities $32.35M $32.21M $33.63M $31.78M $31.78M
Total Non-Current Liabilities $22.34M $21.48M $22.08M $21.84M $21.84M
Long Term Debt and Capital Lease Obligation $7.68M $7.09M $7.48M $5.74M $5.74M
-Long Term Debt $1.48M $1.48M $1.48M $1.96M $1.96M
-Long Term Capital Lease Obligation $6.21M $5.61M $6.01M $3.78M $3.78M
Non-Current Deferred Liabilities $6.96M $6.89M $6.98M $6.94M $6.94M
Other Non-Current Liabilities $7.70M $7.50M $7.62M $9.17M $9.17M
Total Equity $984.71M $995.99M $1.04B $1.11B $1.11B
Stockholders' Equity $990.49M $1.00B $1.05B $1.11B $1.11B
Capital Stock $4,000.00 $4,000.00 $4,000.00 $3,000.00 $3,000.00
-Common Stock $4,000.00 $4,000.00 $4,000.00 $3,000.00 $3,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $531.56M $524.10M $540.14M $574.52M $574.52M
Retained Earnings $462.45M $475.60M $505.13M $529.95M $529.95M
Gains/Losses Not Affecting Retained Earnings -$3.53M $1.92M $4.54M $7.51M $7.51M
Minority Interests -$5.78M -$5.63M -$5.66M -$5.27M -$5.27M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $109.23M -$23.76M $7.10M -$101.64M -$78.14M
Net cash flow from continuing operations $109.23M -$23.76M $7.10M -$101.64M -$78.14M
Net Income from Continuing Operations -$13.34M -$29.72M -$25.27M -$61.63M -$23.65M
Gain/Loss from Continuing Operations -$5,000.00 -$71,000.00 -$9,000.00 -$65,000.00 -$41,000.00
Depreciation & Depletion & Amortization $6.82M $7.68M $6.00M $24.12M $6.11M
Deferred Tax $264,000.00 -$200,000.00 -$921,000.00 -$278,000.00 $395,000.00
Other Non-Cash Items $585,000.00 $469,000.00 $353,000.00 $1.79M $563,000.00
Change in Working Capital $108.13M -$15.63M $16.76M -$117.63M -$71.71M
-Change in Receivables $3.19M $729,000.00 $16.43M -$23.25M -$15.38M
-Change in Payables and Accrued Expense $2.79M -$18.11M -$2.53M $9.46M $13.25M
-Change in Other Current Assets -$3.05M $2.28M $2.79M $798,000.00 $1.82M
-Change in Other Current Liabilities -$523,000.00 -$505,000.00 -$381,000.00 -$1.63M -$446,000.00
-Change In Other Working Capital $105.73M -$28,000.00 $449,000.00 -$103.02M -$70.96M
Net cash flow from investing -$48.04M $50.80M $10.94M $111.37M $11.15M
Net Cash Flow from Continuing Investing Activities -$48.04M $50.80M $10.94M $111.37M $11.15M
Net PPE Purchase and Sale -$1.79M -$3.86M -$5.19M -$22.57M -$4.98M
Net Business Purchase and Sale -$286,000.00 $0.00 -$55.57M $3.78M $0.00
Net Investment Purchase and Sale -$45.97M $54.66M $71.70M $130.17M $16.13M
Financing Cash Flow -$724,000.00 -$24.23M -$44.83M -$14.79M -$534,000.00
Net Cash Flow from Continuing Financing Activities -$724,000.00 -$24.23M -$44.83M -$14.79M -$534,000.00
Net Issuance Payments Of Debt -$93,000.00 -$88,000.00 -$564,000.00 -$870,000.00 -$88,000.00
Net Common Stock Issuance -$631,000.00 -$24.14M -$44.28M -$13.92M -$447,000.00
Proceeds from Stock Option Exercised $0.00 $2,000.00 $9,000.00 $1,000.00 $1,000.00
Ending Cash Balance $86.92M $26.44M $23.53M $50.33M $50.33M
Net Change in Cash $60.47M $2.82M -$26.80M -$5.06M -$67.52M
Beginning Cash Balance $26.44M $23.53M $50.33M $55.28M $117.78M
Effect of Exchange Rate Changes $14,000.00 $88,000.00 $3,000.00 $105,000.00 $75,000.00
Free Cash Flow $107.44M -$27.62M $1.90M -$124.21M -$83.12M

Discussion

No comments yet — be the first to weigh in on FLGT.

Sign in to join the discussion.

Scroll to Top